loader image
Sunday, November 30, 2025
71.9 F
McAllen
- Advertisement -

Gainey Appointed to Pediatric Acute-Onset Neuropsychiatric Syndrome Advisory Council

Translate to Spanish or other 102 languages!

 Governor Greg Abbott has appointed Summer Gainey, Ph.D. to the Pediatric Acute-Onset Neuropsychiatric Syndrome Advisory Council for a term to set expire on August 31, 2025. Image Source; X. Bgd for illustration purposes
 Governor Greg Abbott has appointed Summer Gainey, Ph.D. to the Pediatric Acute-Onset Neuropsychiatric Syndrome Advisory Council for a term to set expire on August 31, 2025. Image Source; X. Bgd for illustration purposes
- Advertisement -

AUSTIN – Governor Greg Abbott has appointed Summer Gainey, Ph.D. to the Pediatric Acute-Onset Neuropsychiatric Syndrome Advisory Council for a term to set expire on August 31, 2025. The Council advises the commission and the legislature on research, diagnosis, treatment, and education related to pediatric acute-onset neuropsychiatric syndrome.

Summer Gainey, Ph.D. of Anderson is a board certified behavior analyst-doctoral and is currently serving as a quality assurance consultant. She is a member of the Association for Behavior Analysis International, Association of Professional Behavior Analysts, and Texas Association of Behavior Analysis, which she previously served as president. Gainey received a Bachelor of Arts in Psychology from Meredith College and a Doctor of Philosophy in Autism and Developmental Disabilities from The University of Texas at Austin.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.

Educating Older Adults On Age-Related Weight Gain, Dec. 5th

The “Living with Weight Gain” program is part of STHS & Prominence Health’s “Senior Living Seminar Series,” which focuses on providing essential education on common health issues affecting the elderly population
- Advertisement -
×